Categories: Uncategorized

New Meta-Analysis Strengthens Evidence That Nuts May Lower Cardiovascular Risk

BARCELONA, Spain, Nov. 6, 2024 /PRNewswire/ — A recent systematic review and meta-analysis funded by the International Nut and Dried Fruit Council (INC) has just been published in the prestigious scientific journal Nutrition, Metabolism and Cardiovascular Diseases.[1] The study showed that current evidence provides a good indication that consuming nuts may advantageously affect blood lipids in adults with a mix of health statuses. This may be important for the prevention and treatment of cardiovascular diseases as well as intermediate health conditions such as overweight/obesity, hypertension, and dyslipidemia.

The study analyzed 113 trials that assessed the effect of consuming nuts on blood lipid outcomes. The median daily dose assessed was 45.5 grams of nuts per day compared to a non-nut control.

The findings showed that, overall, nut consumption resulted in moderate reductions in total cholesterol and LDL (“bad”) cholesterol, with small reductions in triglycerides and apolipoprotein B. There was no significant impact on HDL (“good”) cholesterol or other assessed measures.

The researchers concluded that the current evidence supports existing recommendations for the consumption of nuts and for cardiovascular risk reduction by favorably affecting the blood lipid profile in adults. In addition to substantiating current health claims, the findings support health professionals and dietary guidelines in recommending nuts as part of a nutrient-dense dietary pattern for cardiovascular health.

- Advertisement -

“Some recent studies have questioned whether nuts have benefits on cholesterol when there is overwhelming evidence of their benefits on cardiovascular health. This update of the scientific evidence carried out with more than 100 published studies shows that international organizations should without shyness maintain nuts into their recommendations,” commented Prof. Jordi Salas-Salvadó, principal investigator on the study, Professor at Rovira i Virgili University in Reus, Spain.

Dr. Stephanie Nishi, first author of the study, Assistant Professor at Toronto Metropolitan University, Canada, added: “This finding, combined with the extensive body of research on nuts, highlights their status as a powerhouse of healthful nutrients. Nuts provide a unique combination of vitamins, minerals, fiber, and healthy fats, making them a convenient, portable, and satisfying snack or meal addition as part of a healthy dietary pattern.”

Press contact: press@nutfruit.org.

[1] Nishi, S. K., Paz-Graniel, I., Ni, J., Valle-Hita, C., Khoury, N., Garcia-Gavilán, J. F., Babio, N, Salas-Salvadó, J. (2024). Effect of Nut Consumption on Blood Lipids: An updated Systematic Review and Meta-analysis of Randomized Controlled Trials. Nutrition, Metabolism and Cardiovascular Diseases. DOI: 10.1016/j.numecd.2024.10.009

Logo – https://mma.prnewswire.com/media/2451960/INC_Nutfruit_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/new-meta-analysis-strengthens-evidence-that-nuts-may-lower-cardiovascular-risk-302297461.html

Recent Posts

KFSHRC Madinahs Virtual Clinics Wins Award at PX Congress

RIYADH, Saudi Arabia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research…

4 hours ago

IBA Business Update Third Quarter 2024

Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in…

4 hours ago

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR…

4 hours ago

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

– Kura to receive a $330 million upfront payment and up to $1.2 billion in…

4 hours ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Revuforj (revumenib)

LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy,…

4 hours ago

Las Vegas Unveils Exclusive Entertainment, Packages and More for Race Week 2024

Destination Revving up This Year’s Excitement with Top-Tier Entertainment, Luxurious Trackside Experiences and Celebrations like…

7 hours ago